Neovasc Inc. (NVCN.TO)
| Previous Close | 0.9500 |
| Open | 0.9600 |
| Bid | 0.9300 x 0 |
| Ask | 1.0600 x 0 |
| Day's Range | 0.9400 - 0.9800 |
| 52 Week Range | 0.8600 - 3.4800 |
| Volume | 154,413 |
| Avg. Volume | 28,606 |
| Market Cap | 65.557M |
| Beta (5Y Monthly) | 2.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0730 |
| Earnings Date | Nov. 03, 2021 - Nov. 08, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.61 |
- GlobeNewswire
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
Company on Schedule to Commence Trial Late This Year VANCOUVER and MINNEAPOLIS, Sept. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received FDA approval for the Investigational Device Exemption (“IDE”) regarding the COSIRA-II IDE Clinical Trial. Following multiple discussions with FDA over the past several months, the approved protocol for the COSIRA-II study is designed to answer key questions arising
- Newsfile
Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 30, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that its management team will be participating in the 23rd Annual H.C. Wainwright Global Investment Conference to be held September 13-15, 2021. A pre-recorded company presentation will be available beginning at 7:00 am EDT on September 13 through the conference website and the Investor Relations section of the Neovasc
- ACCESSWIRE
Sidoti Microcap Virtual Conference
Presentation Times Released for 50 Presenting Companies Wednesday and Thursday, August 18-19, 2021NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day summer Microcap Virtual Conference taking place Wednesday and Thursday, August 18 - 19, 2021. The links can also be found at www.
